ARMD8 inhibitors represent a class of chemical compounds designed to target and modulate the activity of the ARMD8 protein. These inhibitors function by binding to the active or regulatory sites of the ARMD8 protein, interfering with its natural biochemical processes. Typically, ARMD8 is involved in specific enzymatic or signaling pathways, and its modulation by inhibitors can alter these pathways. The inhibitors are often characterized by their affinity for the protein, with chemical structures optimized to improve selectivity and potency. This ensures minimal off-target interactions while enhancing their ability to specifically engage with ARMD8. The design of ARMD8 inhibitors may involve a range of molecular scaffolds, with variations in functional groups that influence their binding modes and interactions with the target protein.
The development of ARMD8 inhibitors relies heavily on structure-based design, which incorporates data from techniques like X-ray crystallography and molecular modeling to predict the ideal chemical configurations for binding. The inhibitors can have diverse physical and chemical properties, such as variations in solubility, stability, and permeability, which impact their performance in experimental settings. Chemical modifications to the core structure of ARMD8 inhibitors can enhance properties like metabolic stability or improve their interaction with the ARMD8 protein in different environmental conditions, such as changes in pH or ionic strength. These compounds are key tools in research for understanding the biological pathways associated with ARMD8 and for probing the mechanisms that regulate its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Verteporfin is used in photodynamic therapy for AMD and could indirectly affect ARMD8. | ||||||
Zeaxanthin | 144-68-3 | sc-205544 sc-205544A | 500 µg 1 mg | $270.00 $463.00 | 5 | |
These carotenoids are antioxidants used in AMD management, potentially beneficial in conditions involving ARMD8. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is often used in AMD management and could influence processes related to ARMD8. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Vitamin C, as an antioxidant, may have beneficial effects in AMD and indirectly affect ARMD8. | ||||||
Copper | 7440-50-8 | sc-211129 | 100 g | $51.00 | ||
Copper is sometimes used alongside zinc in AMD management, potentially affecting ARMD8. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
Doxycycline has been studied for its potential benefits in AMD, possibly affecting pathways involving ARMD8. | ||||||